2Ishiguro F, Fukui T, Mori S, et al. Serum careinoemhryonie antigen levels as a surrogate marker four the evaluation of tu- mor response to ehemotheray in nonsmall cell lung eaneer[J ]. Ann Throat Cardiovase Surg, 2010, 16(4): 242.
3Wang C Y, Huang M S, Huang M H. Persistently high serum carcinoembryonic antigen levels after surgery indicate poor prognosis in patients with stage I non - small cell lung cancer [J].J Surg Res, 2010, 163(2): e45.
6Mitauhashi N, Takahashi T, Sakruai H, et al. Establishment and characterization of new human lung pooly differentiated adenocarcinorna cell line, GII - 1 produing carcinom- Bryonic antigen (CEA)and CA19 - 9[J]. Lung Cancer, 1995, 12: 13.
7Albain K S, Swarm R S, Rusch V W, et al. Radiotherapy pls chemotherapy with or without surgical resection four stage Ill non - small cell lung cancer: a phase III randomised controlled trial[J]. Lancet, 2009, 374: 379.
二级参考文献8
1Pujol JL, Grenier J, Doures JP, et al. Serum fragment of cytokeratin subnit 19 measured by CyFRA21-1 immunoradiometric assay as a marker of lung cancer. Cancer Res, 1993, 53:61-66.
2Mountain CF. Revisions in the international system for staging lung cancer. Chest, 1997, 111 : 1710-1717.
3Mitauhashi N, T akabashi T , Sakruai H, et al. Establishment and characterization of a new human lung poorly differentiated adenocarcinoma cell line, GLL-1, producing earcinombryonic antigen (CEA) and CA19-9. Lung Cancer, 1995, 12:13-24.
4The World Health Organization histological typing of lung tumors. Second edition. Am J Clin Pathol, 1982, 77:123-136.
